TrialAlimentary pharmacology & therapeutics2026

Clinical Trial: Phase 3 Trial of Resmetirom Versus Placebo in Metabolic Dysfunction-Associated Steatohepatitis-Reanalysis of Fibrosis Stage 2-3 Subset.

Maria Mironova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.